<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Loss of Fic causes progressive neurodegeneration in a Drosophila model of hereditary spastic paraplegia</title></titleStmt>
			<publicationStmt>
				<publisher>Elsevier B.V.</publisher>
				<date>10/01/2024</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10592635</idno>
					<idno type="doi">10.1016/j.bbadis.2024.167348</idno>
					<title level='j'>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</title>
<idno>0925-4439</idno>
<biblScope unit="volume">1870</biblScope>
<biblScope unit="issue">7</biblScope>					

					<author>Amanda G Lobato</author><author>Natalie Ortiz-Vega</author><author>Tijana Canic</author><author>Xianzun Tao</author><author>Nika Bucan</author><author>Kai Ruan</author><author>Adriana P Rebelo</author><author>Rebecca Schule</author><author>Stephan Zuchner</author><author>Sheyum Syed</author><author>R Grace Zhai</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[Hereditary Spastic Paraplegia (HSP) is a group of rare inherited disorders characterized by progressive weakness and spasticity of the legs. Recent newly discovered biallelic variants in the gene FICD were found in patients with a highly similar phenotype to early onset HSP. FICD encodes filamentation induced by cAMP domain protein. FICD is involved in the AMPylation and deAMPylation protein modi昀椀cations of the endoplasmic reticulum (ER) chaperone BIP, a major constituent of the ER that regulates the unfolded protein response. Although several biochemical properties of FICD have been characterized, the neurological function of FICD and the pathological mechanism underlying HSP are unknown. We established a Drosophila model to gain mechanistic understanding of the function of FICD in HSP pathogenesis, and speci昀椀cally the role of BIP in neuromuscular physiology. Our studies on Drosophila Fic null mutants uncovered that loss of Fic resulted in locomotor impairment and reduced levels of BIP in the motor neuron circuitry, as well as increased reactive oxygen species (ROS) in the ventral nerve cord of Fic null mutants. Finally, feeding Drosophila Fic null mutants with chemical chaperones PBA or TUDCA, or treatment of patient 昀椀broblasts with PBA, reduced the ROS accumulation. The neuronal phenotypes of Fic null mutants recapitulate several clinical features of HSP patients and further reveal cellular patho-mechanisms. By modeling FICD in Drosophila, we provide potential targets for intervention for HSP, and advance fundamental biology that is important for understanding related rare and common neuromuscular diseases.]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Hereditary Spastic Paraplegia (HSP) is a diverse collection of Mendelian genetic disorders linked together by the clinical observations of lower limb weakness and spasticity <ref type="bibr">[1,</ref><ref type="bibr">2]</ref>. HSPs may be caused by genetic variants that are autosomal dominant, autosomal recessive, Xlinked, and in the mitochondrial genome <ref type="bibr">[3,</ref><ref type="bibr">4]</ref>. HSP is classi&#26112;&#26880;ed clinically as "uncomplicated or pure" (non-syndromic) or "complicated" (syndromic), which accounts for 90 % or 10 % of patients, respectively. To date, variants in 73 genes have been found to link with HSP <ref type="bibr">[4]</ref><ref type="bibr">[5]</ref><ref type="bibr">[6]</ref>. Due to the wide clinical and genetic heterogeneity of HSP, next generation sequencing approaches have increasingly been incorporated for genetic diagnostics in routine clinical settings <ref type="bibr">[7]</ref>.</p><p>A recent report has identi&#26112;&#26880;ed patients with newly discovered biallelic variants in the FICD gene causing a clinical phenotype consisting of a distinct slowly progressive motor neuron disease, reminiscent of hereditary spastic paraplegia with cerebellar dysfunction and peripheral neuropathy <ref type="bibr">[6]</ref>. FICD, &#26112;&#26880;lamentation induced by cAMP domain protein, is responsible for AMPylation and deAMPylation of its substrate, BIP <ref type="bibr">[8]</ref><ref type="bibr">[9]</ref><ref type="bibr">[10]</ref><ref type="bibr">[11]</ref><ref type="bibr">[12]</ref><ref type="bibr">[13]</ref>. Binding immunoglobulin protein (BIP) is an Hsp70 protein folding chaperone located at the endoplasmic reticulum (ER) <ref type="bibr">[14,</ref><ref type="bibr">15]</ref>. BIP is a major constituent of the ER and regulates the unfolded protein response in the endoplasmic reticulum (UPRER) by gene expression, oligomerization, and AMPylation <ref type="bibr">[8,</ref><ref type="bibr">9,</ref><ref type="bibr">[16]</ref><ref type="bibr">[17]</ref><ref type="bibr">[18]</ref><ref type="bibr">[19]</ref>. AMPylation is a reversible and regulatory post-translational modi&#26112;&#26880;cation <ref type="bibr">[20,</ref><ref type="bibr">21]</ref> that regulates BIP in translocating proteins into the ER, folding and holding protein substrates in the ER, initiating the unfolded protein response, and assisting in ER-associated degradation (ERAD) <ref type="bibr">[15,</ref><ref type="bibr">22]</ref>. The endoplasmic reticulum (ER) plays a major role in maintaining protein homeostasis and is responsible for folding and processing nearly all polypeptides destined for secretion <ref type="bibr">[19,</ref><ref type="bibr">23]</ref>. It is important to note that UPRER is essential for cell homeostasis, thus, any mutations to BIP or FICD will dramatically affect cellular physiology and pathology.</p><p>Although several biochemical properties of FICD have been characterized, the neurological function of FICD and the pathological mechanism underlying HSP are unknown. Given the complexity of the nervous phenotypes of HSP, in vivo modeling is required to dissect the patho-mechanisms. Drosophila has been used successfully to model HSP (Table <ref type="table">1</ref>). For example, HSP caused by loss of Atlastin <ref type="bibr">[24]</ref><ref type="bibr">[25]</ref><ref type="bibr">[26]</ref>, loss of Rtn1 (reticulon) <ref type="bibr">[27]</ref>, and loss of Spastin <ref type="bibr">[28]</ref> was successfully modeled in Drosophila and the underlying mechanisms were found to be involved in many processes including axonal transport, myelination, endomembrane traf&#26112;&#26880;cking, and mitochondria functions. HSP caused by loss of FICD emerged as a good candidate for modeling as Drosophila orthologue Dm Fic shares identical &#26112;&#26880;c core domain and the salt bridge structure with human FICD, and thus, the AMPylation/deAMPylation functions are highly conserved. In this study, we established a Drosophila model to gain mechanistic understanding of the function of FICD in HSP pathogenesis, and speci&#26112;&#26880;cally the role of BIP in neuromuscular physiology.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1</head><p>Drosophila models of HSP. Disease column is classi&#26112;&#26880;ed by its SPG number. Type column is inheritance pattern of autosomal dominant (AD) or autosomal recessive (AR). Gene column is the name of the gene that corresponds to the disease. Protein column is the encoded protein by the gene. Function column is the function of the protein. Drosophila homolog column is the homolog for the human gene that is conserved in Drosophila. Phenotypes column is the previously characterized phenotypes in Drosophila for these proteins.</p><p>Disease Type Gene Protein Function [62] Drosophila homolog Phenotypes SPG3A AD ATL1 Atlastin-1 ER morphogenesis and BMP signaling atl Muscle atl loss causes accumulation of aggregates containing polyubiquitin, decreased volume of endolysosomal network, and decreased lysosome number [63]. TrpA1 activation signi&#26112;&#26880;cantly decreased pupal size, and viability [64]. Adult &#26112;&#27648;ies show progressive decline in climbing ability [65]. Atl is required for normal growth of muscles and synapses at the neuromuscular junction [66]. Atl null &#26112;&#27648;ies were paralyzed by mechanical shock, and showed age-dependent degeneration of dopaminergic neurons [26]. SPG4 AD SPAST Spastin Microtubule severing, ER morphogenesis, endosomal traf&#26112;&#26880;cking, BMP signaling spas At neuromuscular junctions, spastin RNAi causes morphological undergrowth and reduced synaptic area [67]. Neuromuscular junction synaptic boutons in spastin mutants are more numerous and more clustered than in wild-type, and transmitter release is impaired. Spastin null adult &#26112;&#27648;ies have severe movement defects and have short lifespans [68]. SPG7 AR SPG7 Paraplegin Mitochondrial m-AAA ATPase CG2658 Mutants exhibited shortened lifespan, progressive locomotor defects, sensitivity to chemical and environmental stress, and muscular and neuronal degeneration. Also, altered axonal transport of mitochondria, reduced activities of respiratory chain complexes I and II, and severely swollen and dysmorphic mitochondria in the synaptic terminals of photoreceptors [69]. SPG10 AD KIF5A Kinesin heavy chain 5A ATP-dependent motor that move cargoes in the anterograde direction along axons Khc Posterior paralysis, with organelle-&#26112;&#26880;lled axon swellings jammed with cargoes [2,62]. Mutants show disturbed axonal transport, altered structure and function of synapses, behavioral de&#26112;&#26880;cits, and increased mortality [70]. Glial-speci&#26112;&#26880;c downregulation by RNAi suppresses neuronal excitability and results in spastic &#26112;&#27648;ies, as well as peripheral nerves swollen with maldistributed mitochondria [71]. SPG12 AD RTN2 Reticulon 2 ER morphogenesis Rtn1 Loss of Rtn1 depleted ER membrane markers at the presynaptic motor terminals, reductions in activity-evoked Ca 2+ &#26112;&#27648;uxes in the cytosol, ER lumen, and mitochondria, as well as reduced evoked and spontaneous neurotransmission [72]. SPG15 AR ZFYVE26 Spastizin Endosomal traf&#26112;&#26880;cking, autophagy sptz/CG5270 Autophagosome accumulation, enlarged lysosomes, reduced free lysosomes, and locomotor de&#26112;&#26880;cit [73]. SPG17 AD BSCL2 Seipin Lipid droplet biogenesis at ER seipin Mutant &#26112;&#27648;ies have reduced lipid storage in the fat body and accumulate ectopic lipid droplets in the salivary gland [74]. SPG20 AR SPART Spartin Endosomal traf&#26112;&#26880;cking, BMP signaling, mitochondrial regulation spartin Loss of spartin induces age-dependent progressive defects of motor dysfunction and brain neurodegeneration [75]. SPG31 AD REEP1 REEP1 ER morphogenesis and ERmicrotubule interaction reepA ReepA is upregulated under stress conditions and aging. Lack of ReepA showed Atf6 and Ire1 activation, expansion of ER sheetlike structures, locomotor dysfunction, and shortened lifespan [76]. SPG35 AR FA2H Fatty acid 2-hydroxylase Myelin lipid hydroxylation fa2h Loss of fa2h revealed behavioral abnormalities, in addition to a shortened lifespan. Alterations in mitochondrial dynamic and autophagy were identi&#26112;&#26880;ed [77]. SPG61 AR ARL6IP1 ADP ribosylation factorlike GTPase 6-interacting protein 1</p><p>Connecting the ER and mitochondria as a member of MAMs</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Arl6IP1</head><p>Loss of Arl6IP1 results in progressive locomotor de&#26112;&#26880;cits and cell non-autonomous accumulation of lipid droplets in axonal glia <ref type="bibr">[78]</ref>. Knockdown of Arl6IP1 lowers Drp1 protein levels, resulting in reduced ER-mitochondrial contacts and impaired mitochondrial load at the distal ends of long motor neurons. Arl6IP1 knockdown also demonstrate impaired autophagic &#26112;&#27648;ux and an accumulation of ubiquitinated proteins <ref type="bibr">[79]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Loss of Fic causes impaired locomotion</head><p>Recently discovered patients with Hereditary Spastic Paraplegia have biallelic variants in FICD <ref type="bibr">[6]</ref>, therefore we set out to characterize nervous system phenotypes associated with loss of Fic in Fic loss-offunction null mutant allele Fic 30C generated by a 101 bp deletion resulting in an early stop codon <ref type="bibr">[12]</ref>. Fic 30C null mutants are viable and fertile with visual system defects <ref type="bibr">[12,</ref><ref type="bibr">29]</ref>. Patients with biallelic variants in FICD have Hereditary Spastic Paraplegia, with common phenotypes of frequent falls, tiptoeing, walking dif&#26112;&#26880;culties, progressive unsteady gait, lower limb weakness, and motor neuropathy <ref type="bibr">[6]</ref>. Modeling clinically relevant phenotypes is a gap of knowledge. Drosophila negative geotaxis behavior is ideal to model human movement and coordination <ref type="bibr">[30,</ref><ref type="bibr">31]</ref>. To assess human disease relevant phenotypes, we recently established an innovative automated geotaxis monitoring system with computerprogrammed motorized tapping and video tracking capabilities <ref type="bibr">[32]</ref>. By extracting information about movement direction, speed, and climbing performance with sub-second resolution, we could dissect the most affected components of locomotor neurocircuitry in this model. Speci&#26112;&#26880;cally, we quantitatively analyzed three features of the movement: speed, distance traveled, and movement direction. Individual &#26112;&#27648;y vertical positions (maximum height, 14 cm) were used to calculate a cohort's climbing speed and total distance traveled. The difference in SD of horizontal (0 &#231; ) and vertical (-90 &#231; and 90 &#231; ) positions was used to calculate movement direction. Speci&#26112;&#26880;cally, for a given &#26112;&#27648;y, movement direction = (SD of y coordinates -SD of x coordinates)/(SD of y coordinates + SD of x coordinates).</p><p>To assess the age-dependent locomotor phenotype of Fic mutants, we &#26112;&#26880;rst examined the locomotor activity in high resolution of female and male control &#26112;&#27648;ies (w 1118 ) and Fic null mutant &#26112;&#27648;ies (Fic 30C ), at 5, 20, and 27 DAE (days after eclosion). Interestingly, Fic null mutant females have reduced movement direction (Fig. <ref type="figure">1A</ref>), and reduced average speed (Fig. <ref type="figure">1B</ref>) at all ages compared to their age-matched controls; while Fic null mutant males showed signi&#26112;&#26880;cant reduction of movement direction at 20 DAE (Fig. <ref type="figure">1C</ref>), and reduced speed at 27 DAE compared to controls (Fig. <ref type="figure">1D</ref>). When the distance traveled was analyzed using a kymograph, we found that the Fic null mutants, both males and females climb a shorter distance when compared to w 1118 at all ages (Fig. <ref type="figure">1E-J</ref>). Collectively, these results indicate that loss of Fic causes progressive locomotion impairment. Our results uncovered more severe and earlier onset movement phenotypes in females, suggesting a possible female vulnerability of loss of Fic.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Loss of Fic mutants recapitulate patient neurodegeneration phenotype</head><p>Patients with biallelic variants in FICD have common phenotypes of frequent falls, tiptoeing, walking dif&#26112;&#26880;culties, and progressive unsteady gait, all movement phenotypes associated with loss of coordination <ref type="bibr">[6]</ref>. Normal Drosophila negative geotaxis behavior is a smooth upward motion that requires precise coordination, a lack of which results in falls and often followed by compensatory jumps <ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref>. To model diseaserelevant coordination phenotype, we created a novel negative geotaxis monitoring output to track slips, falls, and jumps. Speci&#26112;&#26880;cally, "slips" are de&#26112;&#26880;ned as a negative (downward) distance between -4.7 to -11.7 mm, corresponding to 2-5 body-lengths of a fruit &#26112;&#27648;y; "falls" are de&#26112;&#26880;ned as a negative distance greater than -11.7 mm, corresponding to &gt;5 bodylengths of a fruit &#26112;&#27648;y; and "jumps" are de&#26112;&#26880;ned as a positive (upward) distance &gt;4.7 mm, corresponding to &gt;2 body lengths of a fruit &#26112;&#27648;y. The number of incidences of each event per climbing trial track was recorded and analyzed. For "slip" events, Fic 30C mutant females showed a sig-ni&#26112;&#26880;cant, and progressive increase in slip incidence at 20 and 27 DAE, while Fic 30C mutant males showed an even earlier onset at 5 DAE (Fig. <ref type="figure">2A-B</ref>). A representative distribution of the number of slip incidences at 20 DAE is shown in Fig. <ref type="figure">2C</ref>, and other age-dependent time-points of 5 DAE and 27 DAE are respectively shown in Fig. <ref type="figure">S1A</ref>, S1B. For "fall" events, Fic 30C mutants showed a signi&#26112;&#26880;cant increase in incidence at 27 DAE for females, and an even earlier progressive phenotype starting at 20 DAE for males (Fig. <ref type="figure">2D-E</ref>). A representative distribution of the number of fall incidences at 20 DAE is shown in Fig. <ref type="figure">2F</ref>, and other age-dependent time-points of 5 and 27 DAE are respectively shown in Fig. <ref type="figure">S1C</ref>, <ref type="figure">D</ref>. Lastly, for "jump" events, Fic 30C mutants showed a signi&#26112;&#26880;cant increase starting at the earliest age of 5 DAE (Fig. <ref type="figure">2G-H</ref>). A representative distribution of the number of jump incidences at 20 DAE is shown in Fig. <ref type="figure">2I</ref>, and other age-dependent time-points of 5 DAE and DAE are respectively shown in Fig. <ref type="figure">S1E</ref>, <ref type="figure">F</ref>. Taken together, the analysis of behavior coordination shows that loss of Fic resulted in a progressive de&#26112;&#26880;ciency of coordination and balance, re&#26112;&#27648;ected by increased frequency of slips and falls, and recovery jump attempts. These phenotypes closely track clinical presentations, and successfully recapitulate salient features of adult-onset, progressive movement phenotypes of Hereditary Spastic Paraplegia.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Loss of Fic leads to altered BIP levels and distribution in ventral nerve cord</head><p>Previous studies have demonstrated that FICD localizes to the ER and its primary target is the ER molecular chaperone binding immunoglobulin protein (BIP) <ref type="bibr">[9,</ref><ref type="bibr">11,</ref><ref type="bibr">13]</ref>. BIP is expressed in all cells, including motor neurons, interneurons, and giant &#26112;&#26880;ber neurons. To assess whether the unfolded protein response is being activated by BIP in an agedependent manner, an immuno&#26112;&#27648;uorescence approach was used to observe endogenous BIP expression in the axon tracks including those of the giant &#26112;&#26880;ber of the ventral nerve cord (Fig. <ref type="figure">3A</ref>). To con&#26112;&#26880;rm the expression of BIP in large axon tracks including those of the giant &#26112;&#26880;bers and to assess the giant &#26112;&#26880;ber axon morphology in the ventral nerve cord, we expressed tdTomato and mitoGFP in the giant &#26112;&#26880;ber using R68A06-GAL4 <ref type="bibr">[36]</ref>, speci&#26112;&#26880;cally expressed in the giant &#26112;&#26880;ber neurons <ref type="bibr">[37]</ref><ref type="bibr">[38]</ref><ref type="bibr">[39]</ref>. As shown in Fig. <ref type="figure">3A</ref>, BIP positive puncta were detected in the axon and terminals in the medial VNC including the giant &#26112;&#26880;ber axons, overlapping with the R68A06 positive tdTomato and mitoGFP signal.</p><p>We developed a novel method for analyzing BIP in the ventral nerve cord (Fig. <ref type="figure">S2A-D</ref>). The cell bodies of the giant &#26112;&#26880;ber axons are located in the brain. ER has been shown to be present in the neuronal axons and synaptic terminals <ref type="bibr">[40]</ref><ref type="bibr">[41]</ref><ref type="bibr">[42]</ref>. Given the large size and volume of cytoplasm in the long axons of large neurons such as human motor neurons and Drosophila giant &#26112;&#26880;bers, analyzing the ER in the axons would be highly relevant to understanding axonal pathology in human motor neuron diseases. The anatomy of the Drosophila giant &#26112;&#26880;ber axons is morphologically large and particularly feasible for this analysis. Furthermore, the Drosophila giant &#26112;&#26880;ber neuron is homologous to human upper motor neurons <ref type="bibr">[43,</ref><ref type="bibr">44]</ref>. Given the manifestation of FICD associated HSP in upper motor neurons <ref type="bibr">[6]</ref>, we focused on this area and carried out quantitative analysis on BIP localization.</p><p>After observing the pattern of giant &#26112;&#26880;ber axons, we used their anatomical location to assess BIP patterns in our HSP model. When BIP expression in axon tracks in the ventral nerve cord including giant &#26112;&#26880;ber axons was examined in control w 1118 and Fic 30C &#26112;&#27648;ies at 5 and 20 DAE (Fig. <ref type="figure">3B</ref>), we observed a signi&#26112;&#26880;cant decrease of BIP intensity at 5 DAE but an increase of BIP at 20 DAE in both female and male Fic null mutants compared to their respective controls (Fig. <ref type="figure">3C</ref>), suggesting an agedependent alteration of BIP in loss of Fic neurons. Next, we analyzed the clustering of BIP as a proxy for ER morphology. The endoplasmic reticulum has a mean size of 1 &#956;m <ref type="bibr">[45]</ref>, hence, we separated BIP clusters into sizes of small (&lt;1.5&#956;m 2 ), and large (&gt;3&#956;m 2 ). We observed that at 20 DAE for Fic null females, there is a signi&#26112;&#26880;cant increase in small BIP clusters, and an increasing trend for large BIP clusters (Fig. <ref type="figure">3D</ref>). Collectively, size distribution analysis of BIP clusters showed that BIP clustering is highly dynamic, consistent with an active role in the cellular unfolded protein response in the ER. The remarkable changes speci&#26112;&#26880;cally in the population of small BIP clusters further indicate a critical role of Fic in regulating the dynamic cellular process of small BIP cluster formation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Chemical chaperones reduce ROS accumulation in Fic null mutant tissue and HSP patient &#26112;&#26880;broblasts</head><p>The loss of proteostasis and subsequent accumulation of unfolded and misfolded proteins is a central molecular hallmark of aging and many degenerative diseases <ref type="bibr">[23]</ref>. ER stress and activation of the unfolded protein response has been implicated in abnormal protein processing for the pathogenesis of these diseases, leading to the accumulation of reactive oxygen species (ROS) <ref type="bibr">[46]</ref>. ROS are small, shortlived, and highly reactive molecules generated by the UPR-regulated oxidative folding machinery in the ER and in the mitochondria <ref type="bibr">[47]</ref>. They can be free radicals derived from oxygen, including anionic superoxide or the hydroxyl radical, or nonradical molecule such as hydrogen peroxide <ref type="bibr">[48]</ref>. The ER maintains a relatively high turn-over of reactive oxygen species as its oxidative protein folding machinery through disul&#26112;&#26880;de bonds <ref type="bibr">[49,</ref><ref type="bibr">50]</ref>. BIP has been identi&#26112;&#26880;ed as a redox signaling protein, and redox &#26112;&#27648;uctuations within the ER can be detrimental to protein stability and homeostasis <ref type="bibr">[48,</ref><ref type="bibr">51]</ref>. To analyze ROS levels in vivo, we performed live tissue staining with dihydroethidium (DHE). DHE staining can react with superoxide anions and form a red &#26112;&#27648;uorescence, and has been widely used to evaluate ROS production in tissue and in vivo <ref type="bibr">[52,</ref><ref type="bibr">53]</ref>. Quantitative imaging analysis of DHE &#26112;&#27648;uorescence in female &#26112;&#27648;y brain and ventral nerve cord showed a signi&#26112;&#26880;cant increase in Fic null &#26112;&#27648;ies, compared to that in control &#26112;&#27648;ies (Fig. <ref type="figure">4A</ref>, <ref type="figure">B</ref>), suggesting an accumulation of ROS in the central nervous system of loss of Fic mutants.</p><p>Loss of Fic induced ER stress and accompanied ROS accumulation point to the unfolded protein and proteotoxic stress as a potential cellular target for FICD disease pathology. There have been several therapeutic compounds that have ameliorated phenotypes of Drosophila models of HSP (Table <ref type="table">2</ref>). To expand on this and to facilitate therapeutic discovery, we explored the bene&#26112;&#26880;cial effect of chemical chaperones. Chemical chaperones have been identi&#26112;&#26880;ed and implicated as potential treatments for ER-stress pathologies <ref type="bibr">[54]</ref>. Chemical chaperones are low molecular weight compounds that mimic the functions of intracellular molecular chaperones by increasing the stability of native proteins and assisting refolding of unfolded polypeptides <ref type="bibr">[55,</ref><ref type="bibr">56]</ref>. Two chemical chaperones approved by the US Food and Drug Administration, namely, 4-phenylbutyric acid (4-PBA) and tauroursodeoxycholic acid (TUDCA) are for clinical use in urea-cycle disorders in humans and as a liverprotecting agent in human cholestatic liver diseases, respectively <ref type="bibr">[47,</ref><ref type="bibr">56]</ref>. Administration of PBA or TUDCA has been observed to reduce reactive oxygen species and endoplasmic reticulum stress, respectively, in Drosophila models <ref type="bibr">[57,</ref><ref type="bibr">58]</ref>.</p><p>To determine the effect of PBA or TUDCA on loss of Fic phenotypes in our HSP model, Fic 30C female mutant &#26112;&#27648;ies were fed with 2 mM PBA, mM TUDCA, or vehicle (H 2 O) containing food for 5 days, and compared to w 1118 control &#26112;&#27648;ies (Fig. <ref type="figure">4A</ref>, <ref type="figure">B</ref>). The dosing concentration of PBA, mM, and TUDCA, 10 mM were selected and determined based on previous studies <ref type="bibr">[57,</ref><ref type="bibr">58]</ref>. ROS accumulation and high-resolution negative geotaxis behavior were assessed as functional readouts. ROS accumulation in the brain of Fic 30C mutants was reduced with feeding of either chemical chaperone (Fig. <ref type="figure">4C</ref>), while ROS accumulation in the ventral nerve cord of Fic 30C mutants was reduced only by PBA (Fig. <ref type="figure">4D</ref>). The analysis of average speed showed an improvement at 5 DAE speci&#26112;&#26880;cally with the chemical chaperone PBA (Fig. <ref type="figure">4E</ref>), however, at a later stage, DAE, drug treatment signi&#26112;&#26880;cantly reduced climbing speed in both control and Fic mutant &#26112;&#27648;ies, indicating a possible general toxicity of longterm treatment (Fig. <ref type="figure">4E-F</ref>).</p><p>To explore the therapeutic potential of chemical chaperones for HSP and to expand our &#26112;&#26880;ndings of ROS reduction in human cells, we evaluated the effect of PBA treatment on ROS level in FICD patient &#26112;&#26880;broblasts. We assessed the cellular ROS with live imaging (Fig. <ref type="figure">5A</ref>). Consistent with the &#26112;&#26880;ndings from Drosophila nervous system, we observed a signi&#26112;&#26880;cant reduction of ROS intensity in patient-derived &#26112;&#26880;broblasts with PBA treatment (Fig. <ref type="figure">5B</ref>). Collectively, these results indicate the initial bene&#26112;&#26880;cial effect of chemical chaperones, speci&#26112;&#26880;cally PBA, for reducing reactive oxygen species accumulation and improving cellular health.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Discussion</head><p>Hereditary Spastic Paraplegias are a group of rare inherited disorders characterized by progressive weakness and spasticity of the legs. In this study, we established a Drosophila model to gain mechanistic understanding of the function of FICD in Hereditary Spastic Paraplegia pathogenesis. We discovered that Fic null &#26112;&#27648;ies have locomotor impairment recapitulating salient features of FICD patient neurodegenerative phenotypes. Our cellular analysis uncovered an age-dependent increase of BIP, accounting for the prolonged ER stress. Strikingly, alleviation of ER stress by reduction of reactive oxygen species with chemical chaperone PBA feeding, reversed this impact. By modeling FICD neurodegeneration in Drosophila, we provide mechanistic insights into disease pathology, uncover potential targets for intervention, and advance fundamental </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 2</head><p>Therapeutic compounds for HSP. Treatment column describes which compound was tested. Drosophila HSP homolog column describes which model was used for testing the speci&#26112;&#26880;c compound. The phenotype column describes which phenotypes were restored with treatment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatment</head><p>Drosophila HSP homolog Phenotype Rapamycin atl Partially suppressed the behavioral consequences of both neuronal and muscle atl knockdown, and delayed polyubiquitin aggregate accumulation and degeneration of thoracic muscles <ref type="bibr">[25,</ref><ref type="bibr">80]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Vinblastine</head><p>Alleviates synapse and muscle defects in atl mutants <ref type="bibr">[66]</ref>. spas Increase in eclosion rate, improvement in locomotor ability and adult lifespan, increase in total synaptic area and decrease in bouton number <ref type="bibr">[81]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Phenazine</head><p>Rescued the negative geotaxis defects caused by spastin loss of function <ref type="bibr">[82]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methylene blue</head><p>Rescued the negative geotaxis defects caused by spastin loss of function and re-adjusted the ER stress response biomarker levels back to wild-type <ref type="bibr">[80,</ref><ref type="bibr">82]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>N-acetyl-cysteine</head><p>Rescued the ER stress, lifespan, and locomotor defects <ref type="bibr">[80,</ref><ref type="bibr">82]</ref>. Naringenin reepA Restores ER homeostasis, climbing capacity, and lifespan defects <ref type="bibr">[76]</ref>. Liver X receptor agonist Arl6IP1 Rescues ER disruption within axons and improves ER and mitochondrial organization within motor neurons, and improves locomotor ability <ref type="bibr">[78]</ref>. Verapamil sptz/CG5270 Reduced the number of autophagosomes accumulated, improved lysosomal function and autophagosome degradation, and rescued locomotor defects <ref type="bibr">[73]</ref>. Bay K8644 2&#8242;,5&#8242;dideoxyadenosine SMER28 biology that is important for understanding related rare and common diseases.</p><p>Our novel negative geotaxis monitoring output for slips, falls, and jumps is a tremendous advantage for modeling human disease related locomotion phenotypes. A recent study found patients with biallelic variants in FICD having common phenotypes of frequent falls, tiptoeing, walking dif&#26112;&#26880;culties, and progressive unsteady gait <ref type="bibr">[6]</ref>. In our study, the coordinate matrix output for slips/falls/jumps is constrained within the duration of negative geotactic behavior. This precisely monitors only loss of coordination during intentional movement such as walking, rather than a general locomotion or balance phenotype, speci&#26112;&#26880;cally pertaining to the disease phenotype as seen in patients. Interestingly, we observed a more severe phenotypes in falls/slips/jumps in males, suggesting a possible male vulnerability of loss of Fic, which may underly the fact that more male patients were reported.</p><p>FICD is the enzyme for post-translational AMPylation and deAMPylation modi&#26112;&#26880;cation <ref type="bibr">[20]</ref>. So far the only substrate identi&#26112;&#26880;ed for FICD is BIP, an ER chaperone that regulates the UPRER <ref type="bibr">[8]</ref><ref type="bibr">[9]</ref><ref type="bibr">[10]</ref><ref type="bibr">[11]</ref><ref type="bibr">[12]</ref><ref type="bibr">[13]</ref>. The UPRER is essential for cell homeostasis, thus, any mutations to FICD or BIP will dramatically affect cellular physiology and pathology. There have been several studies performed to assess FICD and BIP functions. For example, Drosophila lacking FICD were viable and fertile, but blind due to compromised visual neurotransmission, assessed by electroretinogram <ref type="bibr">[29,</ref><ref type="bibr">59]</ref>. In another study conducted, it was found that BIP null &#26112;&#27648;y mutants die early in development and this lethality is rescued by including a copy of the genomic transgene expressing a wild-type or AMPylation-resistant mutant <ref type="bibr">[29]</ref>. Overall, when BIP is AMPylated, the ER-transmembrane signaling molecules (ATF6, IRE1, and PERK) and ER-associated caspases (murine caspase-12/human caspase 4) are maintained in an inactive state through binding to GRP78 (BIP). After ER stress, such as protein misfolding, the survival pathways are activated to block further damage. However, when the stress is too severe, apoptotic responses are triggered, which eventually lead to cell death <ref type="bibr">[15]</ref>. Our in vivo observation suggests that prolonged ER stress will lead to BIP upregulation as an early-stage response to ER stress. A previous in silico study has found that BIP clustering facilitates protein folding in the endoplasmic reticulum through cooperative action via entropic pulling where a greater degree of BIP clustering under conditions of ER stress was observed <ref type="bibr">[60]</ref>. This is consistent with our &#26112;&#26880;ndings of more small and intense BIP clusters in the Fic null mutants than that in controls as a result of increased ER stress in loss of Fic.</p><p>The current HSP treatments available are limited to physical therapy, oral antispastic drugs, botulinum toxin therapy, and surgical baclofen pump implantation. In this study, chemical chaperones PBA and TUDCA were tested as potential treatments to reduce the ER reactive oxygen species phenotype. PBA has been effective in children with urea-cycle disorders, and has been considered a promising candidate for the treatment of thalassemias, chemotherapy reagent, cystic &#26112;&#26880;brosis, and neurodegenerative diseases <ref type="bibr">[56,</ref><ref type="bibr">57]</ref>. The mechanism of action is not fully understood, however, it is proposed in assisting protein folding by stabilizing the misfolded proteins, reducing their aggregation, assisting in transportation to the correct subcellular localization, as well as alleviating ER stress through HDAC inhibitor activity <ref type="bibr">[56]</ref>. On the other hand, TUDCA has been effective in primary biliary cirrhosis and has an antiapoptotic mechanism by phosphorylation and inactivation of the proapoptotic factors, prevention of Bax translocation and cytochrome-C release, or stabilization of the lipid and protein structure of mitochondrial outer membranes <ref type="bibr">[47,</ref><ref type="bibr">56]</ref>. In addition to blocking apoptosis, TUDCA appears to inhibit cell death by activating survival pathways such as p38/Erk/Mapk and PI3K signaling cascades <ref type="bibr">[56]</ref>. In this study, we took advantage of the Drosophila nervous system and administered the chemical chaperones through diet, as well as treating patientderived &#26112;&#26880;broblasts. We found that the chemical chaperones were able to improve the average speed at an early age, as well as the accumulation of reactive oxygen species both in vitro and in vivo, ameliorating the disease phenotype at an early stage. Due to the possibility of a long-term general toxicity, this indicates that the chemical chaperones may have an early therapeutic window, and further work is required to optimize the choice and dosage of chemical chaperones to achieve bene&#26112;&#26880;cial effects without long-term toxicity. Overall, our study underscores the utilization of a Drosophila model for HSP and the therapeutic potential of chemical chaperones including PBA for Hereditary Spastic Paraplegia.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1.">Drosophila stocks and experimental procedures</head><p>Flies were maintained on a cornmeal-molasses-yeast medium at 22 &#231; C, 65 % humidity, with 12-h light/12-hour dark cycles. The following &#26112;&#27648;y strains were used in the studies: w 1118 , obtained from Bloomington Drosophila Stock Center (BDSC 3605), UAS-mito-GFP/UASnls-GFP; R68A06-GAL4/Cd4tdTomato (generated by recombining with BDSC 39449 <ref type="bibr">[36]</ref>), and w; Fic 30C ;UAS-Fic E247G obtained from Dr. Helmut Kramer's laboratory <ref type="bibr">[12,</ref><ref type="bibr">29]</ref>.The Fic 30C mutant allele was generated by CRISPR on a w 1118 background. The w 1118 was hence used as the control for the experiment. The original stock obtained from the Kramer lab is the recombined Fic 30C ;UAS-Fic E247G . We have isolated the Fic 30C allele through backcrossing to w 1118 strain. w 1118 was used as a control for this study due to the background of Fic 30C stock line.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2.">Antibodies and reagents</head><p>The following commercially available primary antibodies were used: rabbit anti-GRP78 (abcam, 108615, 1:250). The following secondary antibodies were used: Alexa Fluor Cy5-conjugated anti-rabbit secondary antibody (Rockland, 611-110-122, 1:300).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.">Fly dissection and immunohistochemical staining</head><p>Flies were dissected in phosphate-buffered saline (PBS, pH 7.4). Samples were &#26112;&#26880;xed in 4 % formaldehyde for 15 min and washed in PBS containing 0.4 % v/v Triton X-100 (PBTX). Samples were then incubated with primary antibodies diluted in 0.4 % PBTX with 5 % normal goat serum at 4 &#231; C overnight, followed by incubation with secondary antibodies diluted in 0.4 % PBTX with normal goat serum at 4 &#231; C overnight, as well as DAPI staining (1:300, Invitrogen, D1306) at room temperature for 15 min. The samples were mounted on glass slides with VECTA-SHIELD Antifade Mounting Medium (Vector Laboratories).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.4.">Automated geotaxis monitoring</head><p>Behavior assay was performed using previously published methods <ref type="bibr">[61]</ref>. Each vial was preloaded with f7 &#26112;&#27648;ies; the geotaxis of each &#26112;&#27648;y was recorded with a digital camera (ImagingSource LLC, model no. DMK23U445). Matlab (Mathworks) was used for analysis. Individual &#26112;&#27648;y vertical positions (maximum height, 14 cm) were used to calculate a cohort's climbing rate. Finally, the difference in SD of horizontal and vertical positions was used to calculate movement direction. Specifically, for a given &#26112;&#27648;y, movement direction = (SD of y coordinates -SD of x coordinates)/(SD of y coordinates + SD of x coordinates). For slips/ falls/jumps, the coordinate matrix output is taken from the &#26112;&#27648;y tracking software and coordinates are removed after &#26112;&#27648;ies have reached the top of the vial because our interest pertains only to the negative geotactic behavior. The cutoff is within an average &#26112;&#27648;y axis length (10 pixels) from the ROI de&#26112;&#26880;ned at the top of the vial. Once the coordinates are pruned, the y-displacement of every frame is calculated by subtracting y-coordinates in a frame by the preceding frame. Slips, falls, and jumps are de&#26112;&#26880;ned in terms of the average &#26112;&#27648;y axis length in pixels. Slips are de&#26112;&#26880;ned as 2-5 &#26112;&#27648;y lengths (between -20 and -50 pixels), falls as 5+ &#26112;&#27648;y lengths (&lt;-50 pixels), and jumps as &gt;2 &#26112;&#27648;y lengths (+20 pixels). The number of instances of each action is summed for all tracks within the genotype of interest and each sum is divided by the number of tracks to &#26112;&#26880;nd the average instances per track.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.5.">Reactive oxygen species live imaging</head><p>ROS levels were assessed using live staining DHE, a &#26112;&#27648;uorescent probe for superoxide and hydrogen peroxide.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.5.1.">DHE staining in Drosophila</head><p>Samples were dissected in warm Schneider's media, then incubated in 30 &#956;M DHE for 15 min. The samples washed with PBS 3 times (5 min each), and a &#26112;&#26880;nal wash with PBTX for 5 min. The samples were mounted on glass slides with VECTASHIELD Antifade Mounting Medium, and immediately imaged using an Olympus IX81 confocal microscope with oil immersion objective lens.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.5.2.">DHE staining in &#26112;&#26880;broblasts</head><p>Patient &#26112;&#26880;broblasts were obtained from previous study <ref type="bibr">[6]</ref>. Fibroblasts were cultured in DMEM medium (Corning, 15-013-CV) supplemented with 10 % fetal bovine serum (ATCC, 30-2020) at 37 &#231; C with 5 % CO 2 in the VWR symphony incubator. The cells were seeded in live cell image dishes (SPL Life Sciences, 200350) with 50 % con&#26112;&#27648;uence. 24 h later, the cells were treated with 2 mM PBA for 3 days. Then, the cells were washed with fresh medium and treated with 5 &#956;M of DHE (Thermo, D11347) in 200 &#956;L of fresh medium for 15 min and were imaged immediately. Images were processed using Olympus FluoView 10-ASW software and analyzed using ImageJ software.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.6.">Confocal image acquisition and processing</head><p>Slides were imaged using an Olympus IX81 confocal microscope with 20&#215; or 40&#215; oil immersion objective lens with a scan speed of 8.0 &#956;s per pixel and spatial resolution of 1,024 &#215; 1,024 pixels. Images were processed using FluoView 10-ASW (Olympus). Quanti&#26112;&#26880;cation was carried out using ImageJ/Fiji (1.53q;NIH).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.7.">Drug administration</head><p>Sodium phenylbutyrate (PBA) (Sigma, SML0309) or Tauroursodeoxycholic Acid (TUDCA) (EMD Millipore, 580549) was dissolved in water and then mixed into 10 mL of &#26112;&#27648;y food at a &#26112;&#26880;nal concentration of 2 mM and 10 mM, respectively. An equal amount of water was mixed into the &#26112;&#27648;y food as a control. The vials were dried at room temperature for 12 h before feeding.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.8.">Statistics</head><p>No statistical methods were used to predetermine sample size. Data were analyzed Prism (Graphpad Software). Student's t-test was used for comparison of two groups. One-way ANOVA with Tukey's post-hoc corrections were used for comparison of more than two groups. P &lt; 0.05 was considered statistically signi&#26112;&#26880;cant. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CRediT authorship contribution statement</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Declaration of competing interest</head><p>Authors declare that they have no competing interests.</p></div></body>
		</text>
</TEI>
